Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Biomerieux distributed a product correction notice in september 2010 regarding the performance of piperacillin/tazobactam (tzp) with e.Coli and k.Pneumoniae on the vitek 2 gram negative susceptibility test cards. further performance testings revealed overcalling resistance issues for additional species. these species include e.Coli k. pneumoniae m. morganii p. mirabilis p. vulgaris p. rettgeri p. stuartii p. aeruginosa s. enterica.
Model Catalog: 22293 (Lot serial: All lot numbers); Model Catalog: 22250 (Lot serial: All lot numbers); Model Catalog: 22246 (Lot serial: All lot numbers); Model Catalog: 22225 (Lot serial: All lot numbers); Model Catalog: 22224 (Lot serial: All lot numbers); Model Catalog: 22214 (Lot serial: All lot numbers); Model Catalog: 22245 (Lot serial: All lot numbers); Model Catalog: 22244 (Lot serial: All lot numbers); Model Catalog: 22230 (Lot serial: All lot numbers); Model Catalog: 22229 (Lot serial: All lot numbers); Model Catalog: 22228 (Lot serial: All lot numbers); Model Catalog: 22227 (Lot serial: All lot numbers); Model Catalog: 410102 (Lot serial: All Lot Numbers); Model Catalog: 410101 (Lot serial: All Lot Numbers); Model Catalog: 22295 (Lot serial: All Lot Numbers)